Just before the May 5 trial date set for Novartis and Incyte to finally hash out their Jakafi royalty dispute in court, the ...

Havas Life has put down roots in the Middle East. The agency’s newest office will provide healthcare advertising and ...

As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the ...

Bristol Myers Squibb helmsman Chris Boerner joined a growing list of life sciences leaders announcing major U.S. investments in the face of potential pharmaceutical import tariffs. | Bristol Myers ...

After revealing in February plans to save $2 billion more on top of a previously disclosed cost-cutting initiative, Bristol ...

The executive order adds on to Trump’s planned tariffs on pharmaceuticals in his overall strategy to onshore production of medicines. At the White House event, Trump told reporters that he will ...

A little over a month after announcing her departure from Moderna, Kate Cronin has begun her “next adventure.” Cronin has ...

As BioNTech progresses with its goal to grow into a “fully integrated immunotherapy powerhouse,” the German biotech is e | ...

AbbVie snagged yet another spot among April’s highest TV ad spenders, as its Vraylar jumped two spots to eighth place with a ...

As sure as the sun rises, prescription medicine use and total drug spending continue to increase in the U.S. | Last year's ...

Four weeks ago, after a Houston judge denied J&J’s third attempt to resolve approximately 90,000 talcum powder lawsuits ...